IMVT Oct 2024 20.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 12:32PM EDT. Market open.
| Previous close | 11.21 |
| Open | 11.21 |
| Bid | 9.70 |
| Ask | 12.10 |
| Strike | 20.00 |
| Expiry date | 2024-10-18 |
| Day's range | 11.21 - 11.21 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
Insider MonkeyShould You Hold Immunovant (IMVT)?
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. The fund advanced 8.92% (Institutional Shares) in the quarter compared to an 8.52% gain for the Russell 3000 Health Care Index (benchmark) and a 10.56% increase for the S&P […]
ZacksHere's Why You Should Add Immunovant (IMVT) to Your Portfolio
Immunovant's (IMVT) late-stage studies evaluating its lead candidate, batoclimab, for various autoimmune indications are progressing well. Several data readouts are expected in 2024 and 2025.
ZacksWhat Makes Immunovant (IMVT) a New Buy Stock
Immunovant (IMVT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
© 2024 Yahoo. All rights reserved.